SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTRPRNewsWire • 03/26/22
Bristol Myers, Nektar Melanoma Doublet Therapy Trial Fails To Show Clinical BenefitBenzinga • 03/14/22
Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors Following Announcement of Update from Bristol-Myers Squibb and Nektar on the PIVOT-IO-001 Phase 3 TrialPRNewsWire • 03/14/22
Nektar's stock falls 44% after experimental therapy fails to work in melanoma patientsMarket Watch • 03/14/22
Nektar Therapeutics' (NKTR) CEO Howard Robin on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/01/22
Nektar Therapeutics (NKTR) Reports Q4 Loss, Lags Revenue EstimatesZacks Investment Research • 03/01/22
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2021 on Monday, February 28, 2022, After Close of U.S.-Based Financial MarketsPRNewsWire • 02/17/22
Nektar Therapeutics' President and CEO, Howard Robin, to Present at the 40th Annual J.P. Morgan Virtual Healthcare ConferencePRNewsWire • 01/05/22
Is the Options Market Predicting a Spike in Nektar Therapeutics (NKTR) Stock?Zacks Investment Research • 12/31/21
Nektar Therapeutics Announces Phase 1b Data for Novel T Regulatory Cell Stimulator NKTR-358 (LY3471851) in Patients with Atopic DermatitisPRNewsWire • 12/15/21
Nektar Therapeutics Presents Clinical Data for NKTR-255 in Patients with Relapsed/Refractory Hematologic Malignancies, Including Patients with Prior CAR-T Therapy, at the 63rd American Society of Hematology (ASH) Annual MeetingPRNewsWire • 12/13/21
Nektar Therapeutics Announces Data Presentations for its Immuno-Oncology Programs at the European Society for Medical Oncology Immuno-Oncology (ESMO-IO) Congress 2021 and the 63rd American Society of Hematology (ASH) Annual MeetingPRNewsWire • 11/30/21
Nektar Therapeutics Strengthens Board of Directors with Appointment of Diana M. Brainard, M.D.PRNewsWire • 11/15/21
Nektar Therapeutics Announces Data Presentations for Its Immuno-Oncology Pipeline at the 2021 Society for Immunotherapy of Cancer (SITC) Annual MeetingPRNewsWire • 11/12/21
Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors with Cancer Specialist During 2021 Society for Immunotherapy of Cancer (SITC) 36th Annual MeetingPRNewsWire • 11/09/21